Premium Content Oncology – Journal Spy Journal Spy, Cancer, All oncology, Breast cancer, COVID-19 Room Collateral damage: the impact on outcomes from cancer surgery of the COVID-19 pandemic. ClinOwl May 22, 2020
Oncology – Journal Spy Journal Spy, Cancer, All oncology, Breast cancer Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study. ClinOwl Apr 12, 2020
Artificial intelligence could help breast screening save more lives Premium Content Features and Comments, Cancer, All oncology, Breast cancer Artificial intelligence could help breast screening save more lives Cancer Research UK Feb 17, 2020
DNA methylation markers predict recurrence-free interval in triple-negative breast cancer Premium Content Oncology – Journal Spy All oncology, Breast cancer DNA methylation markers predict recurrence-free interval in triple-negative breast cancer OnMedica Jan 31, 2020
NEPA efficacy and tolerability during (neo)adjuvant breast cancer chemotherapy with cyclophosphamide and doxorubicin Premium Content Oncology – Journal Spy All oncology, Breast cancer, Supportive and palliative care NEPA efficacy and tolerability during (neo)adjuvant breast cancer chemotherapy with cyclophosphamide and doxorubicin OnMedica Jan 29, 2020
Linkage Between Obesity Leptin and Breast Cancer Premium Content Oncology – Journal Spy All oncology, Breast cancer Linkage Between Obesity Leptin and Breast Cancer OnMedica Jan 10, 2020
Simple blood test for early detection of breast cancer Premium Content NCRI Cancer Conference News, Cancer, All oncology, Breast cancer Simple blood test for early detection of breast cancer OnMedica Nov 03, 2019
Two studies show CDK4/6 inhibitors improve overall survival in advanced breast cancer Premium Content ESMO Congress News, Cancer, All oncology, Breast cancer Two studies show CDK4/6 inhibitors improve overall survival in advanced breast cancer OnMedica Oct 11, 2019
Immune therapy eliminates tumour cells in early triple negative breast cancer Premium Content ESMO Congress News, Cancer, All oncology, Breast cancer Immune therapy eliminates tumour cells in early triple negative breast cancer OnMedica Oct 11, 2019
